Mirae Asset Global Etfs Holdings Ltd. Ovid Therapeutics Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 30,913 shares of OVID stock, worth $32,767. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,913Holding current value
$32,767% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OVID
# of Institutions
75Shares Held
39.2MCall Options Held
10.3KPut Options Held
200-
Rubric Capital Management LP New York, NY5.32MShares$5.63 Million0.12% of portfolio
-
Madison Avenue Partners, LP New York, NY4.08MShares$4.33 Million0.53% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$4.23 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$4.09 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.09MShares$3.27 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $74.6M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...